The Chemours Company (CC)
Price:
12.95 USD
( - -0.20 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Air Products and Chemicals, Inc.
VALUE SCORE:
6
2nd position
Eastman Chemical Company
VALUE SCORE:
11
The best
Oil-Dri Corporation of America
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
NEWS
AutoZone's Q1 Results: Revenue Growth Amid EPS Miss and LIFO Charges
gurufocus.com
2025-12-09 15:14:00AutoZone (AZO) reported its Q1 results, showing a decline in EPS by 4.6% to $31.04, marking the sixth consecutive quarter of missing estimates. Revenue rose 8.2
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
businesswire.com
2025-12-04 16:30:00WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel.
Reviewing Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Chemours (NYSE:CC)
defenseworld.net
2025-12-01 01:28:51Chemours (NYSE: CC - Get Free Report) and Kiwa Bio-Tech Products Group (OTCMKTS:KWBT - Get Free Report) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability. Insider and Institutional Ownership 76.3% of
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs
fool.com
2025-11-30 15:40:35New York City-based Cooper Creek Partners bought nearly 4 million shares of The Chemours Company in the third quarter. The shares were worth about $63.1 million at the end of the quarter.
Head to Head Survey: Chemours (NYSE:CC) and Avient (NYSE:AVNT)
defenseworld.net
2025-11-29 01:39:04Chemours (NYSE: CC - Get Free Report) and Avient (NYSE: AVNT - Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk. Dividends Chemours pays an annual dividend of $0.35 per
On Holding Surges 19% on Strong Q3 Earnings and Raised Guidance
gurufocus.com
2025-11-12 11:14:00On Holding (ONON) saw a significant 19% increase in its stock after a strong Q3 earnings report and an upward revision of its guidance. The Swiss athletic footw
Chemours: Solid Momentum Despite One-Time Costs In Q3
seekingalpha.com
2025-11-11 11:14:25Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalization should help results bottom in 6–9 months.
Chemours Q3 Earnings Lag Estimates Amid Operational Disruptions
zacks.com
2025-11-11 08:11:05CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results.
The Chemours Company (CC) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-07 11:46:08The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Arun Viswanathan - RBC Capital Markets, Research Division Joshua Spector - UBS Investment Bank, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies LLC, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Vincent Andrews - Morgan Stanley, Research Division Roger Spitz - BofA Securities, Research Division Aaron Rosenthal - JPMorgan Chase & Co, Research Division Presentation Operator Good morning. My name is Gigi, and I'll be your conference operator today.
Chemours Stock Drops. Here's Why.
barrons.com
2025-11-07 11:33:00Earnings were light, driven by slowing sales of titanium dioxide, a key component of white paint.
Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say
zacks.com
2025-11-06 20:01:36The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Chemours (CC) Q3 Earnings Miss Estimates
zacks.com
2025-11-06 19:51:14Chemours (CC) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.4 per share a year ago.
The Chemours Company Reports Third Quarter 2025 Results
businesswire.com
2025-11-06 16:30:00WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2025 Results.
Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline
zacks.com
2025-10-30 11:01:39Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours (CC) Projected to Post Earnings on Thursday
defenseworld.net
2025-10-30 02:42:45Chemours (NYSE: CC - Get Free Report) is expected to release its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Chemours to post earnings of $0.32 per share and revenue of $1.4994 billion for the quarter. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.Interested persons
Chemours Announces Fourth Quarter Dividend
businesswire.com
2025-10-29 17:00:00WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Fourth Quarter Dividend.
AutoZone's Q1 Results: Revenue Growth Amid EPS Miss and LIFO Charges
gurufocus.com
2025-12-09 15:14:00AutoZone (AZO) reported its Q1 results, showing a decline in EPS by 4.6% to $31.04, marking the sixth consecutive quarter of missing estimates. Revenue rose 8.2
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
businesswire.com
2025-12-04 16:30:00WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel.
Reviewing Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Chemours (NYSE:CC)
defenseworld.net
2025-12-01 01:28:51Chemours (NYSE: CC - Get Free Report) and Kiwa Bio-Tech Products Group (OTCMKTS:KWBT - Get Free Report) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability. Insider and Institutional Ownership 76.3% of
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs
fool.com
2025-11-30 15:40:35New York City-based Cooper Creek Partners bought nearly 4 million shares of The Chemours Company in the third quarter. The shares were worth about $63.1 million at the end of the quarter.
Head to Head Survey: Chemours (NYSE:CC) and Avient (NYSE:AVNT)
defenseworld.net
2025-11-29 01:39:04Chemours (NYSE: CC - Get Free Report) and Avient (NYSE: AVNT - Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk. Dividends Chemours pays an annual dividend of $0.35 per
On Holding Surges 19% on Strong Q3 Earnings and Raised Guidance
gurufocus.com
2025-11-12 11:14:00On Holding (ONON) saw a significant 19% increase in its stock after a strong Q3 earnings report and an upward revision of its guidance. The Swiss athletic footw
Chemours: Solid Momentum Despite One-Time Costs In Q3
seekingalpha.com
2025-11-11 11:14:25Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalization should help results bottom in 6–9 months.
Chemours Q3 Earnings Lag Estimates Amid Operational Disruptions
zacks.com
2025-11-11 08:11:05CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results.
The Chemours Company (CC) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-07 11:46:08The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Arun Viswanathan - RBC Capital Markets, Research Division Joshua Spector - UBS Investment Bank, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies LLC, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Vincent Andrews - Morgan Stanley, Research Division Roger Spitz - BofA Securities, Research Division Aaron Rosenthal - JPMorgan Chase & Co, Research Division Presentation Operator Good morning. My name is Gigi, and I'll be your conference operator today.
Chemours Stock Drops. Here's Why.
barrons.com
2025-11-07 11:33:00Earnings were light, driven by slowing sales of titanium dioxide, a key component of white paint.
Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say
zacks.com
2025-11-06 20:01:36The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Chemours (CC) Q3 Earnings Miss Estimates
zacks.com
2025-11-06 19:51:14Chemours (CC) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.4 per share a year ago.
The Chemours Company Reports Third Quarter 2025 Results
businesswire.com
2025-11-06 16:30:00WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2025 Results.
Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline
zacks.com
2025-10-30 11:01:39Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours (CC) Projected to Post Earnings on Thursday
defenseworld.net
2025-10-30 02:42:45Chemours (NYSE: CC - Get Free Report) is expected to release its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Chemours to post earnings of $0.32 per share and revenue of $1.4994 billion for the quarter. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.Interested persons
Chemours Announces Fourth Quarter Dividend
businesswire.com
2025-10-29 17:00:00WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Fourth Quarter Dividend.